| Financial Year |
March 31 2023 |
| Monetary Funds |
1,469,396,456.06 |
| Held-for-trading Financial Assets |
357,880,000.00 |
| Notes Receivable |
2,699,977.52 |
| Accounts Receivable |
144,756,256.94 |
| Advances to Suppliers |
40,571,724.91 |
| Other Receivables |
27,100,787.08 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
13,605,966.00 |
| Inventories |
851,103,674.04 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
19,900,783.09 |
| Other Current Assets |
103,314,002.06 |
| Total Current Assets |
3,022,039,029.49 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
13,939,785.50 |
| Long-term Equity Investment |
160,185,985.74 |
| Investment Properties |
-- |
| Fixed Assetes |
402,916,872.24 |
| Under-construction Projects |
291,969,144.16 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
289,270,280.89 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
7,283,451.21 |
| Deferred Income Tax Assets |
85,124,160.74 |
| Other Non-Current Assets |
14,322,863.95 |
| Sub-Total of Non-Current Assets |
1,335,701,272.95 |
| Total Assets |
4,357,740,302.44 |
| Short-Term Loans |
159,659,634.03 |
| Trading Financial liabilities |
-- |
| Notes Payable |
116,054,205.55 |
| Accounts Payable |
206,616,328.35 |
| Accounts Received In Advance |
101,754,238.14 |
| Employee Compensation Payable |
29,226,329.49 |
| Taxes Payable |
2,462,789.92 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
49,223,795.89 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
131,081,219.93 |
| Other Current Liabilities |
31,215,539.56 |
| Sub-Total of Current Liabilities |
881,378,804.30 |
| Long-term Loans |
621,520,837.98 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
54,433,268.17 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
720,673,562.59 |
| Total Liabilities |
1,602,052,366.89 |
| Paid-In Capital(Or Share Stock) |
457,107,538.00 |
| Capital Surplus |
1,543,948,489.41 |
| Surplus Reserve |
75,519,782.06 |
| LESS:Treasury Stock |
19,377,297.59 |
| Undistributed Profits |
611,579,116.62 |
| Minority Stockholder's Interest |
81,286,253.88 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,674,401,681.67 |
| Owner's Equity（Stockholder's Equity） |
2,755,687,935.55 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,357,740,302.44 |
